✦ LIBER ✦

Different lineage involvement in myelodysplastic/myeloproliferative disease with combined MPLW515L and JAK2V617F mutation

✍ Scribed by Kais Hussein; Katharina Theophile; Thomas Buhr; Alexandra Beller; Hans Kreipe; Oliver Bock

Book ID: 108676275
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 262 KB
Volume: 145
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2009.07671.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TG101209, a small molecule JAK2-selectiv

TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations

✍ Pardanani, A; Hood, J; Lasho, T; Levine, R L; Martin, M B; Noronha, G; Finke, C; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 512 KB

The JAK2 V617F mutation occurs frequentl

The JAK2 V617F mutation occurs frequently in myelodysplastic/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis

✍ Kremer, M; Horn, T; Dechow, T; Tzankov, A; Quintanilla-Martínez, L; Fend, F 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 67 KB

The JAK2 V617F mutation involves B- and

The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders

✍ Thomas Stauffer Larsen; Jacob Haaber Christensen; Hans Carl Hasselbalch; Niels P 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 756 KB

Reply to Kremer M et al., The JAK2 V617F

Reply to Kremer M et al., The JAK2 V617F mutation occurs frequently in myelodysplastic/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis

✍ Ohyashiki, K; Ohyashiki, J H 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 67 KB

Prognostic interaction between thrombocy

Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis

✍ Atallah, E; Nussenzveig, R; Yin, C C; Bueso-Ramos, C; Tam, C; Manshouri, T; Pier 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 111 KB

JAK2 (V617F) as an acquired somatic muta

JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders

✍ Elisa Rumi; Francesco Passamonti; Daniela Pietra; Matteo G. Della Porta; Luca Ar 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 1 views